Global  

Celebrating 10 Years of Trusted News Discovery
One News Page
> >

Opioid Company Executives Go to Trial on Conspiracy Charges

Video Credit: Newsy Studio - Duration: 00:57s - Published < > Embed
Opioid Company Executives Go to Trial on Conspiracy Charges

Opioid Company Executives Go to Trial on Conspiracy Charges

Insys Therapeutics founder John Kapoor is accused of running a bribery scheme in which the company paid doctors to prescribe its fentanyl product.

0
shares
ShareTweetSavePostSend
 

Opioid Company Executives Go to Trial on Conspiracy Charges

The trial  for opioid company executives accused of running an illegal bribery scheme started Monday in Boston.

Insys Therapeutics  founder John Kapoor and other former employees face charges tied to claims that they paid doctors to prescribe their fentanyl product in order to boost profits.  The drug in question is Subsys, an under-the-tongue fentanyl product.

It's FDA-approved for severe cancer pain, but Insys is accused of bribing doctors to prescribe it to patients who didn't need the powerful narcotic.  In court , prosecutors argued that the conspiracy contributed to the national opioid epidemic.

Kapoor's attorney denied that, saying Subsys makes up less than 1 percent of U.S. opioid prescriptions.  U.S. attorneys say they'll call two former  Insys executives  who've pleaded guilty in the case to testify against Kapoor.  According to Bloomberg , the trial could last around three months and will likely serve as an indicator for how juries may handle similar opioid-related claims. 




You Might Like


Tweets about this

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2019 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? FeedbackSend us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest
One News® is a registered trademark of One News Page Ltd.